# A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping

> **NCT04269408** · PHASE2 · COMPLETED · sponsor: **BIT Pharma GmbH** · enrollment: 41 (actual)

## Conditions studied

- Aneurysmal Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Nicardipine
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT04269408
- **Lead sponsor:** BIT Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-05
- **Primary completion:** 2022-05-12
- **Final completion:** 2023-01-23
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2023-07-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04269408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04269408, "A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04269408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*